Innovation Pharmaceuticals Inc (IPIX)

[LIVED]

“Was wondering about the 6% and feel it is in line or a bit better than what most small biotech companies get for these deals.”

Not even close. More typical would be 20-25% royalty plus a supply agreement of COGS plus 5 to 10%.

Typical would be 1-25% depending on the phase. The most would go for a phase 3, obviously. So, 6% is right in line.